AmySClarkMD

PubMed

• A Quantitative Bias Analysis Approach to Informative Presence Bias in Electronic Health Records.
  Hanxi Zhang, Rebecca A Hubbard, Amy S Clark> ;Epidemiology. 2024 May 1
• Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
  Beverly Kyalwazi, Christina Yau, Michael J Campbell, Toshio F Yoshimatsu, A Jo Chien, Anne M Wallace, Andres Forero-Torres, Lajos Pusztai, Erin D Ellis, Kathy S Albain...> ;JAMA Network Open. 2023 Dec 1
• 2 citations
  Estrogen Receptor-Targeted and Progesterone Receptor-Targeted PET for Patients with Breast Cancer.
  Gary A Ulaner, Amy M Fowler, Amy S Clark, Hannah Linden> ;PET Clinics. 2023 Oct 1
• 20 citations
  Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-F-Fluoro-17β-Fluoroestradiol.
  Gary A Ulaner, David A Mankoff, Amy S Clark, Amy M Fowler, Hannah M Linden, Lanell M Peterson, Farrokh Dehdashti, Brenda F Kurland, Joanne Mortimer, Jason Mouabbi, Dae...> ;Journal of Nuclear Medicine. 2023 Mar 1
• 1 citations
  Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast c...
  Mark Jesus M Magbanua, Laura van 't Veer, Amy S Clark, A Jo Chien, Judy C Boughey, Hyo S Han, Anne Wallace, Heather Beckwith, Minetta C Liu, Christina Yau, E Paul Wile...> ;Breast Cancer Research and Treatment. 2023 Apr 1
• 2 citations
  Acute skin radiation toxicity seen with concurrent T-DM1: A single institutional report of 35 patients.
  Sana Sara Dastgheyb, Kristine Kim, Abigail Doucette, Gary Freedman, Payal Shah, Igor Makhlin, Amy Clark, Neil Taunk> ;Breast. 2023 Feb 1
• 7 citations
  Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
  Elias, A., Julie E Lang, Andres Forero-Torres, Douglas Yee, Christina Yau, Denise Wolf, John Park, Barbara A Parker, A Jo Chien, Anne M Wallace, Rashmi Murthy, Kathy S...> ;NPJ Breast Cancer. 2022 Dec 1
• 2 citations
  Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.
  Igor Makhlin, Nicholas P McAndrew, E Paul Wileyto, Amy S Clark, Robin Holmes, Lisa N Bottalico, Clementina Mesaros, Ian A Blair, Grace R Jeschke, Kevin R Fox, Susan M ...> ;NPJ Breast Cancer. 2022 Nov 11
• 7 citations
  F-FDG PET/CT for the Evaluation of Therapy Response in Hormone Receptor-Positive Bone-Dominant Metastatic Breast Cancer.
  Igor Makhlin, Katrina Esther Korhonen, Melissa Lynne Martin, Jennifer Gillman, Erin Schubert, Austin Ryan Pantel, David A Mankoff, Amy S Clark> ;Radiology. Imaging Cancer. 2022 Nov 1
• 2 citations
  Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update Q and A.
  Amy S Clark, Erin F Cobain, Zoneddy Dayao, Mark R Somerfield, Angela DeMichele, N Lynn Henry> ;JCO Oncology Practice. 2022 Dec 1
• 16α-[F]Fluoro-17β-Estradiol Positron Emission Tomography to Measure Regional Estrogen Receptor Expression in Breast Cancer.
  David A Mankoff, Amy S Clark, Christine E Edmonds, Sophia R O'Brien, Austin R Pantel> ;Journal of Clinical Oncology. 2022 Nov 1
• 9 citations
  Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer tri...
  M Marczyk, A Mrukwa, C Yau, D Wolf, Y-Y Chen, R Balassanian, R Nanda, B A Parker, G Krings, H Sattar, J C Zeck, K S Albain, J C Boughey, M C Liu, A D Elias, A S Clark,...> ;Annals of Oncology. 2022 Aug 1
• 9 citations
  Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States.
  Ravi B Parikh, Samuel U Takvorian, Daniel Vader, E Paul Wileyto, Amy S Clark, Daniel J Lee, Gaurav Goyal, Gabrielle B Rocque, Efrat Dotan, Daniel M Geynisman, Pooja Ph...> ;Journal of the National Cancer Institute. 2022 Apr 11
• Navigating Systemic Therapeutic Options for First-Line Metastatic Hormone Receptor-Positive, ERBB2-Negative Breast Cancer Treatment.
  Yehoda M Martei, Amy S Clark> ;JAMA Network Open. 2022 Apr 1
• 3 citations
  Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab.
  Elizabeth W Thompson, Biniyam G Demissei, Amanda M Smith, Priya Brahmbhatt, Jessica Wang, Amy Clark, Angela DeMichele, Vivek Narayan, Payal Shah, Lova Sun, Benedicte L...> ;JACC. Basic to Translational Science. 2022 Jan 1
• 2 citations
  Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer.
  Emily A Verbus, Alexander J Rossi, Amy S. Clark, Neil K. Taunk, Anupma Nayak, Jonathan M. Hernandez, Julia Tchou> ;Annals of Surgical Oncology. 2021 Nov 16
• 34 citations
  Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
  Elias, A., Amy S. Clark, Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, Laura J. van't Veer, Douglas Yee, Stacy L. Moulder, Anne M. Wallace, A. Jo Chien, Claudin...> ;Nature Communications. 2021 Nov 5
• 16 citations
  Safety of cyclin-dependent kinase4/6 inhibitor combined with palliative radiotherapy in patients with metastatic breast cancer.
  K. Kim, Payal D. Shah, Amy S. Clark, Gary M. Freedman, Sana Dastgheyb, Andrew R. Barsky, Alexandra Dreyfuss, Neil K. Taunk> ;Breast. 2021 Oct 9
• 12 citations
  Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
  Douglas Yee, Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar, Andres Forero-Torres, A. Jo Chien, Anne M. Wallace, Lajos Pusztai, Kath...> ;NPJ Breast Cancer. 2021 Oct 5
• 1 citations
  Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer
  Ravi B. Parikh, Samuel U Takvorian, Daniel Vader, E. Paul Wileyto, Amy S. Clark, Daniel J. Lee, Gaurav Goyal, Gabrielle B. Rocque, Efrat Dotan, Daniel M. Geynisman, Po...> ;Medrxiv. 2021 Sep 23
• 38 citations
  Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clini...
  W. Fraser Symmans, Christina Yau, Yunn Yi Chen, Ronald Balassanian, Molly Klein, Lajos Pusztai, Rita Nanda, Barbara A. Parker, Brian Datnow, Gregor Krings, Shi Wei, Mi...> ;JAMA Oncology. 2021 Sep 16
• 120 citations
  Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial
  Lajos Pusztai, Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace, Erica String-Reasor, Judy C. Boughey, A. Jo Chien, Anthony D. Elias, Heather Beckwi...> ;Cancer Cell. 2021 Jul 12
• 13 citations
  In vivo visualization of PARP inhibitor pharmacodynamics
  Elizabeth S. McDonald, Austin R. Pantel, Payal D. Shah, Michael D. Farwell, Amy S. Clark, Robert K. Doot, Daniel A. Pryma, Sean Carlin> ;JCI Insight. 2021 Apr 22
• 39 citations
  Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2- Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1).
  Aditya Bardia, Sara A. Hurvitz, Angela DeMichele, Amy S. Clark, Amelia Zelnak, Denise A. Yardley, Meghan Sri Karuturi, Tara Sanft, Sibel Blau, Lowell L. Hart, Cynthia ...> ;Clinical Cancer Research. 2021 Aug 1
• 10 citations
  Setting the Pick: Can PI3K Inhibitors Circumvent CDK4/6 Inhibitor Resistance?
  Amy S. Clark, Igor Makhlin, Angela DeMichele> ;Clinical Cancer Research. 2021 Jan 15
• Join now to see all

Journal Articles

• Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer  
  Austin D Williams, Amy S Clark, Paul J Zhang, Julia Tchou, Bruce L Levine, Jennifer M Matro, Laurence J Cooper, Alycia So, Lynn M Schuchter, Carl H June, Angela M DeMi..., Clinical Cancer Research